On October 23, 2026, Edesa Biotech’s Board of Directors approved significant increases in the annual base salaries of key executives. Dr. Pardeep Nijhawan, Dr
Who to call at Edesa Biotech, and when
A new leader at Edesa Biotech brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Edesa Biotech raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Edesa Biotech, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Edesa Biotech
Location
100 SPY COURT
Markham, Ontario, Canada
About
Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases. Our most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. Edesa is currently evaluating EB05 in a Phase 3 study as a potential treatment for Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of respiratory failure. In addition, Edesa is developing an sPLA2 inhibitor, EB01, as a topical treatment for chronic Allergic Contact Dermatitis (ACD), a common occupational skin condition. The company has also received regulatory approval to conduct a Phase 2 trial its EB06 monoclonal antibody as a treatment for vitiligo, a life-altering autoimmune disease that causes skin to lose its color in patches. We also are planning a future Phase 2 study of paridiprubart for systemic sclerosis (scleroderma), an autoimmune rheumatic disorder that causes fibrosis (scarring/hardening) of skin and internal organs.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Edesa Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MarkhamBiotechnologyTherapeuticsPharmaceuticalBiopharma